argenx SE | Investor Presentation Deck | 22 slides

argenx · 2023-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
front_matter
Open slide detailBeat · WhyLoop · Golden Circle
04
The slide uses a circular graphic to emphasize the 'revolution' theme and highlights the company's focus on targeted treatment modalities.present_solution
Open slide detailBeat · WhatLoop · Golden Circle
05
The slide uses a circular photo collage of patients to emphasize the human element of the treatment goals.present_solution
Open slide detailBeat · WhatLoop · Golden Circle
06
The slide uses a hub-and-spoke style diagram to connect the company vision to four strategic pillars.summarize
Open slide detailBeat · WhatLoop · Golden Circle
07
The slide uses a waterfall-style bar chart to show quarterly revenue growth throughout the year.summarize
Open slide detailBeat · HowLoop · Golden Circle
08
The slide uses a three-column layout for clinical data and a footer for scientific validation.summarize
Open slide detailBeat · HowLoop · Golden Circle
09
The diagram uses a clover-like circular arrangement to represent interconnected strategic pillars.summarize
Open slide detailBeat · HowLoop · Golden Circle
10
The slide uses a hub-and-spoke style layout to connect a central commercial goal to specific strategic pillars.present_solution
Open slide detailBeat · HowLoop · Golden Circle
11
The slide uses a hub-and-spoke visual metaphor to connect the clinical class to the list of autoantibodies.present_framework
Open slide detailBeat · HowLoop · Golden Circle
12
The slide uses a pyramid-like structure to display patient population sizes for different medical conditions.size_opportunity
Open slide detailBeat · HowLoop · Golden Circle
13
The slide uses a timeline structure to map clinical development stages against specific disease indications and their associated U.S. patient prevalence numbersplan_implementation
Open slide detailBeat · HowLoop · Golden Circle
14
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.present_solution
Open slide detailBeat · HowLoop · Golden Circle
15
Includes immunofluorescence microscopy images and bar charts/traces showing physiological recovery.summarize
Open slide detailBeat · HowLoop · Golden Circle
16
Includes a biological mechanism diagram on the left and a clinical trial timeline/roadmap on the right.plan_implementation
Open slide detailBeat · HowLoop · Golden Circle
17
The slide uses a circular, overlapping design to categorize medical indications by therapeutic area.present_framework
Open slide detailBeat · HowLoop · Golden Circle
18
The slide uses a network-like background to visually connect the logos, implying a collaborative ecosystem.establish_context
Open slide detailBeat · HowLoop · Golden Circle
19
plan_implementation
Open slide detailBeat · HowLoop · Golden Circle
20
The slide uses a hub-and-spoke diagram to center the company brand around its core values.summarize
Open slide detailBeat · HowLoop · Golden Circle
21
The chart uses color-coding to represent therapeutic areas: Neurology (light green), Hematology and Rheumatology (light blue), Dermatology (dark blue), and Nephplan_implementation
Open slide detailBeat · HowLoop · Golden Circle
22
The slide outlines a multi-stage clinical trial process including an open-label phase followed by a placebo-controlled relapse-based study.present_framework